Liposome disposition in vivo. III. Dose and vesiclesize effects, Biochim. Biophys. Acta, vol.666, pp.493-503, 1981. ,
New photosensitizers for photodynamic therapy, Biochem. J, vol.473, pp.347-364, 2016. ,
Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats, Colloids Surf. B Biointerfaces, vol.84, pp.329-337, 2011. ,
Regulatory pathways in photodynamic therapy induced apoptosis, Photochem. Photobiol. Sci. Off. J. Eur. Photochem. Assoc. Eur. Soc. Photobiol, vol.3, pp.721-729, 2004. ,
Photodynamic therapy of cancer: An update. CA, Cancer J. Clin, vol.61, pp.250-281, 2011. ,
Liposome: classification, preparation, and applications, Nanoscale Res. Lett, vol.8, p.102, 2013. ,
Oncologic photodynamic therapy photosensitizers: a clinical review, Photodiagnosis Photodyn. Ther, vol.7, pp.61-75, 2010. ,
Intracellular signaling mechanisms in photodynamic therapy, Biochim. Biophys. Acta, vol.1704, pp.59-86, 2004. ,
Liposomes entrapping ?-cyclodextrin/ibuprofen inclusion complex: Role of the host and the guest on the bilayer integrity and microviscosity, Chem. Phys. Lipids, vol.209, pp.61-65, 2017. ,
Toxicological Comparison of Cyclodextrins, Proceedings of the Eighth International Symposium on Cyclodextrins, J. Szejtli, and L, 1996. ,
, , pp.149-155
Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomes, J. Drug Target, vol.14, pp.225-232, 2006. ,
Recent Findings on Safety Profiles of Cyclodextrins, Cyclodextrin Conjugates, and Polypseudorotaxanes, Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine, pp.91-122, 2011. ,
Cyclodextrins as Drug Carrier Molecule: A Review, Sci. Pharm, vol.76, pp.567-598, 2008. ,
Novel tretinoin formulations: a drug-in-cyclodextrin-in-liposome approach, J. Liposome Res, vol.23, pp.211-219, 2013. ,
Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy, RSC Adv, vol.2, pp.11169-11183, 2012. ,
The high photoactivity of m-THPC in photodynamic therapy. Unusually strong retention of m-THPC by RIF-1 cells in culture, Photochem. Photobiol, vol.69, pp.360-363, 1999. ,
Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope, J. Mol. Biol, vol.8, pp.660-670, 1964. ,
Diffusion of univalent ions across the lamellae of swollen phospholipids, J. Mol. Biol, vol.13, pp.238-265, 1965. ,
Doxil®--the first FDA-approved nano-drug: lessons learned, J. Control. Release Off. J. Control. Release Soc, vol.160, pp.117-134, 2012. ,
Clinical development of photodynamic agents and therapeutic applications, Biomater. Res, vol.22, 2018. ,
, , 2016.
, Verteporfin. Dev. Ophthalmol, vol.55, pp.330-336
,
Photophysical properties of glucoconjugated chlorins and porphyrins and their associations with cyclodextrins, J. Photochem. Photobiol. B, vol.81, pp.154-162, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00016449
Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment, Molecules, vol.23, 1936. ,
URL : https://hal.archives-ouvertes.fr/hal-02058223
meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity, Br. J. Cancer, vol.54, pp.717-725, 1986. ,
, , 2010.
, Comparative in vitro study on the characteristics of different photosensitizers employed in PDT, J. Photochem. Photobiol. B, vol.100, pp.173-180
Long-term outcomes following Foscan®-PDT of basal cell carcinomas, Lasers Surg. Med, vol.44, pp.533-540, 2012. ,
Systems for light application and dosimetry in photodynamic therapy, 1996. ,
, J. Photochem. Photobiol. B, vol.36, pp.153-156
, , 2018.
, Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation, Int. J. Pharm, vol.536, pp.95-107
Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression, Cell Death Differ, vol.11, pp.183-195, 2004. ,
Some important considerations in the use of cyclodextrins, Pharm. Res, vol.16, pp.1796-1798, 1999. ,
Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers, Biochem. J, vol.261, pp.277-280, 1989. ,
Photophysical properties of 5, 20-tetrakis(m-hydroxyphenyl)porphyrin (m-THPP), 5,10,15,20-tetrakis(m-hydroxyphenyl)chlorin (m-THPC) and 5,10,15,20-tetrakis(m-References hydroxyphenyl)bacteriochlorin (m-THPBC): a comparative study, vol.10, pp.325-328, 1999. ,
Photodynamic therapy for cancer of the pancreas, Gut, vol.50, pp.549-557, 2002. ,
, , 2010.
, Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-ßcyclodextrin on drug anesthetic efficacy, J. Liposome Res, vol.20, pp.315-322
(m-hydroxyphenyl)chlorin in rats and humans, Biomed. Chromatogr, vol.5, pp.184-186, 1999. ,
Study of temoporfin metabolism by HPLC and electrospray mass spectrometry, Biomed. Chromatogr. BMC, vol.13, pp.354-359, 1999. ,
Tissue levels, histologic changes and plasma pharmacokinetics of meta-Tetra (hydroxyphenyl) chlorin (mTHPC) in the cat, Lasers Med. Sci, vol.17, pp.79-85, 2002. ,
Cyclodextrin-Drug Inclusion Complexes: In Vivo and In Vitro Approaches, Int. J. Mol. Sci, vol.20, 2019. ,
Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization, Photodiagnosis Photodyn. Ther, vol.1, pp.279-293, 2004. ,
Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death, Photodiagnosis Photodyn. Ther, vol.2, pp.1-23, 2005. ,
Photodynamic therapy and antitumour immunity, Nat. Rev. Cancer, vol.6, pp.535-545, 2006. ,
Cell death by mitotic catastrophe: a molecular definition, Oncogene, vol.23, pp.2825-2837, 2004. ,
,
, , 2011.
, The encapsulation of ?-lapachone in 2-hydroxypropyl-?-cyclodextrin inclusion complex into liposomes: a physicochemical evaluation and molecular modeling approach, Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci, vol.44, pp.332-340
Cyclodextrins in drug delivery: An updated review, AAPS PharmSciTech, vol.6, pp.329-357, 2005. ,
Preparation, Characterization and Pharmacokinetics of Liposomes-Encapsulated Cyclodextrins Inclusion Complexes for Hydrophobic Drugs, Drug Deliv, vol.14, pp.201-208, 2007. ,
, , 2014.
, Drug-in-cyclodextrin-in-liposomes: a promising delivery system for hydrophobic drugs, Expert Opin. Drug Deliv, vol.11, pp.565-577
The Stability of Cyclodextrin Complexes in Solution, Chem. Rev, vol.97, pp.1325-1358, 1997. ,
, , 2002.
, Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice, Radiat. Res, vol.158, pp.339-345
Photosensitisersthe progression from photodynamic therapy to anti-infective surfaces, Expert Opin. Drug Deliv, vol.12, pp.85-101, 2015. ,
Review: A History of Cyclodextrins, Chem. Rev, vol.114, pp.10940-10975, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01089582
, , 2011.
, Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?, J. Pharm. Sci, vol.100, pp.2835-2848
A history of photodynamic therapy, Aust. N. Z. J. Surg, vol.61, pp.340-348, 1991. ,
Cyclodextrin-based pharmaceutics: past, present and future, Nat. Rev. Drug Discov, vol.3, pp.1023-1035, 2004. ,
Disposition of [14C]gammacyclodextrin in germ-free and conventional rats, Regul. Toxicol. Pharmacol. RTP, vol.27, pp.150-158, 1998. ,
Cyclodextrins and their uses: a review, Process Biochem, vol.39, pp.1033-1046, 2004. ,
A comparative study of the photosensitizing characteristics of some cyanine dyes, J. Photochem. Photobiol. B, vol.55, pp.27-36, 2000. ,
Curcumin-hybrid Nanoparticles in Drug Delivery System (Review), Asian J. Nanosci. Mater, vol.2, pp.66-91, 2019. ,
A direct sensitized fluorimetric determination of5,10,15,20-tetra(mhydroxyphenyl)chlorin [m-THPC(Foscan)®] in human plasma using a cyclodextrin inclusion complex, Analyst, vol.126, pp.923-927, 2001. ,
ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy, Autophagy, vol.6, pp.838-854, 2010. ,
Curcumin-loaded ?-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma, Nanomedicine Nanotechnol. Biol. Med, vol.8, pp.440-451, 2012. ,
, PHOTODYNAMIC THERAPY OF MALIGNANT TUMOURS. The Lancet, vol.300, pp.1175-1177, 1972.
Photodynamic therapy for cancer, Nat. Rev. Cancer, vol.3, pp.380-387, 2003. ,
Photodynamic therapy in cancer treatment -an update review, J. Cancer Metastasis Treat, p.25, 2019. ,
An update on photodynamic therapy applications, J. Clin. Laser Med. Surg, vol.20, pp.3-7, 2002. ,
Cyclodextrins and Their Inclusion Complexes, Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine, pp.1-18, 2011. ,
Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cellsin vitro, Phys. Med. Biol, vol.50, pp.2597-2616, 2005. ,
Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies, Cancer Res, vol.60, pp.1388-1393, 2000. ,
Photodynamic Therapy Potentiates the Effects of Curcumin on Pediatric Epithelial Liver Tumor Cells, Anticancer Res, vol.36, pp.3363-3372, 2016. ,
Liposomes encapsulating prednisolone and prednisolone-cyclodextrin complexes: comparison of membrane integrity and drug release, Eur. J. Pharm. Sci, vol.13, pp.287-296, 2001. ,
Vascular damage after photodynamic therapy of solid tumors: a view and comparison of effect in pre-clinical and clinical models at the University of Louisville, Vivo Athens Greece, vol.14, pp.93-100, 2000. ,
Daylight Photodynamic Therapy: What is Known and What is Yet to be Determined, Dermatol. Surg. Off. Publ. Am. Soc. Dermatol. Surg. Al, vol.42, pp.286-295, 2016. ,
Synthesis and structure of a 5,15-bis(4-pyridyl)purpurin, Tetrahedron Lett, vol.36, pp.9093-9096, 1995. ,
Cyclodextrin nephrosis in the rat, Am. J. Pathol, vol.83, pp.367-382, 1976. ,
Drug-in-micelles-inliposomes (DiMiL) systems as a novel approach to prevent drug leakage from deformable liposomes, Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci, vol.130, pp.27-35, 2019. ,
, Cyclodextrins in Pharmacy, 1994.
Uptake and photo-toxicity of, 2016. ,
Foslip® and Fospeg® in multicellular tumor spheroids, J. Photochem. Photobiol. B, vol.161, pp.244-252 ,
Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin, Cancer Immunol. Immunother, vol.61, pp.215-221, 2012. ,
Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis, Int. J. Radiat. Oncol. Biol. Phys, vol.78, pp.563-571, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00479855
Photosensitizing efficacy of MTHPC-PDT compared to photofrin-PDT in the RIF1 mouse tumour and normal skin, Int. J. Cancer, vol.60, pp.388-394, 1995. ,
, , 1990.
, Absorption, distribution and excretion of 14C-labelled hydroxypropyl ?cyclodextrin in rats following oral administration, Minutes 5th Int. Symp. Cyclodext. ParisMarch, pp.507-520, 1990.
,
Liposomes incorporating cyclodextrin-drug inclusion complexes: Current state of knowledge, Carbohydr. Polym, vol.129, pp.175-186, 2015. ,
, , 2016.
, Preparation of drug-in-cyclodextrin-in-liposomes at a large scale using a membrane contactor: Application to trans-anethole, Carbohydr. Polym, vol.154, pp.276-286
A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs, BioMed Res. Int, 2015. ,
Development of a new topical system: Drug-in-cyclodextrin-in-deformable liposome, Int. J. Pharm, vol.380, pp.174-180, 2009. ,
Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy, Photochem. Photobiol, vol.67, pp.596-602, 1998. ,
Generation of effective antitumor vaccines using photodynamic therapy, Cancer Res, vol.62, pp.1604-1608, 2002. ,
The antitumor effects of methyl-?-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts, Biochem. Biophys. Res. Commun, vol.455, pp.285-289, 2014. ,
2-Hydroxypropyl-?-cyclodextrin (HP-?-CD): A toxicology review, Food Chem. Toxicol, vol.43, pp.1451-1459, 2005. ,
Drug-carrier potential of liposomes in cancer chemotherapy, Lancet Lond. Engl, vol.1, pp.1313-1316, 1974. ,
Antiproliferative effect of methylbeta-cyclodextrin in vitro and in human tumour xenografted athymic nude mice, Br. J. Cancer, vol.78, pp.1165-1169, 1998. ,
Tetra-n-propylporphycene as a tumour localizer: pharmacokinetic and phototherapeutic studies in mice, Cancer Lett, vol.44, pp.1-6, 1989. ,
Lipophilic drug derivatives in liposomes, Int. J. Pharm, vol.165, pp.129-168, 1998. ,
Cyclodextrin-membrane interaction in drug delivery and membrane structure maintenance, Int. J. Pharm, vol.564, pp.59-76, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02092355
Photodynamic treatment as a novel approach in the therapy of arthritic joints, Lasers Surg. Med, vol.40, pp.265-272, 2008. ,
Integrity of liposomes in presence of cyclodextrins: Effect of liposome type and lipid composition, Int. J. Pharm, vol.333, pp.167-176, 2007. ,
How does photodynamic therapy work?, Photochem. Photobiol, vol.55, pp.145-157, 1992. ,
Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy, Cancer Res, vol.45, pp.572-576, 1985. ,
Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors, Cancer Res, vol.64, pp.2120-2126, 2004. ,
mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review, Lasers Surg. Med, vol.47, pp.779-787, 2015. ,
Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation, J. Pharm. Sci, vol.86, pp.147-162, 1997. ,
, , 2005.
, Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes, J. Control. Release Off. J. Control. Release Soc, vol.105, pp.305-317
Advanced in silico modeling explains pharmacokinetics and biodistribution of temoporfin nanocrystals in humans, J. Controlled Release, vol.308, pp.57-70, 2019. ,
Gold nanoparticles as novel agents for cancer therapy, Br. J. Radiol, vol.85, pp.101-113, 2012. ,
Multivesicular liposomes bearing celecoxib-beta-cyclodextrin complex for transdermal delivery, Drug Deliv, vol.14, pp.327-335, 2007. ,
Effect of overall charge and charge distribution on cellular uptake, distribution and phototoxicity of cationic porphyrins in HEp2 cells, J. Photochem. Photobiol. B, vol.100, pp.100-111, 2010. ,
References dehydrocrotonin in liposomes: an enhancement of the antitumor activity, J. Biomed. Nanotechnol, vol.43, pp.499-510, 2011. ,
,
, Fluorescence imaging of Foscan® and Foslip in the plasma membrane and in whole cells, J. Photochem. Photobiol. B, vol.92, pp.47-53
Cyclodextrins for drug delivery, J. Drug Target, vol.18, pp.645-656, 2010. ,
Triggering of apoptosis by cathepsins, Cell Death Differ, vol.8, pp.324-326, 2001. ,
, , 1996.
, Drug solubilization and stabilization, J. Pharm. Sci, vol.85, pp.1017-1025
Pharmaceutical applications of cyclodextrins: basic science and product development, J. Pharm. Pharmacol, vol.62, pp.1607-1621, 2010. ,
Drug Solubilization and Stabilization by Cyclodextrin Drug Carriers, Drug Delivery Strategies for Poorly Water-Soluble Drugs, pp.67-101, 2013. ,
Cyclodextrins and their pharmaceutical applications, Int. J. Pharm, vol.329, pp.1-11, 2007. ,
Self-association of cyclodextrins and cyclodextrin complexes, J. Pharm. Sci, vol.93, pp.1091-1099, 2004. ,
Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes, Int. J. Pharm, vol.298, pp.1-12, 2005. ,
Nanoparticles in Photodynamic Therapy, Chem. Rev, vol.115, pp.1990-2042, 2015. ,
, , 1989.
, Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages, Photochem. Photobiol, vol.49, pp.453-458
Photochemotherapy of tumours with mesotetrahydroxyphenyl chlorin is pH dependent, Cancer Lett, vol.138, pp.197-201, 1999. ,
Basic principles of photodynamic therapy, 2001. ,
, J. Porphyr. Phthalocyanines, vol.5, pp.105-129
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting, Adv. Enzyme Regul, vol.41, pp.189-207, 2001. ,
, , 2005.
, Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery, Int. J. Pharm, vol.298, pp.55-67
Effect of preparation technique on the properties of liposomes encapsulating ketoprofencyclodextrin complexes aimed for transdermal delivery, Int. J. Pharm, vol.312, pp.53-60, 2006. ,
New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics, Int. J. Pharm, vol.395, pp.222-231, 2010. ,
Motexafin gadolinium: A novel redox active drug for cancer therapy, Semin. Cancer Biol, vol.16, pp.466-476, 2006. ,
Modality of cell death induced by Foscan-based photodynamic treatment in human colon adenocarcinoma cell line HT29, Biochem. Biokhimii ? a ?, vol.69, pp.45-49, 2004. ,
Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids, Biochem. Pharmacol, vol.69, pp.1167-1176, 2005. ,
, , 2007.
, Relationship between subcellular localisation of Foscan and caspase activation in photosensitised MCF-7 cells, Br. J. Cancer, vol.96, pp.944-951
Anticancer Drug Delivery: An Update on, Clinically Applied Nanotherapeutics. Drugs, vol.75, pp.1601-1611, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01215444
Clinical application of photodynamic diagnosis and photodynamic therapy for gynecologic malignant diseases: A review, Photodiagnosis Photodyn. Ther, vol.24, pp.52-57, 2018. ,
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res, vol.46, pp.6387-6392, 1986. ,
Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery, J. Drug Target, vol.2, pp.449-454, 1994. ,
Drugs-in-cyclodextrins-in-liposomes: an approach to controlling the fate of water insoluble drugs in vivo, Int. J. Pharm, vol.162, pp.59-69, 1998. ,
Subcellular localization of meta-tetra (hydroxyphenyl) chlorin in human tumor cells subjected to photodynamic treatment, J. Photochem. Photobiol. B, vol.49, pp.96-103, 1999. ,
Enhanced antiproliferative activity of the new anticancer candidate LPSF/AC04 in cyclodextrin inclusion complexes encapsulated into liposomes, AAPS PharmSciTech, vol.13, pp.1355-1366, 2012. ,
Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation, Int. J. Pharm, vol.515, pp.684-691, 2016. ,
Effect of talaporfin sodium-mediated photodynamic therapy on cell death modalities in human glioblastoma T98G cells, J. Toxicol. Sci, vol.39, pp.821-827, 2014. ,
mTHPC-loaded extracellular vesicles outperform liposomal and free mTHPC formulations by an increased stability, drug delivery efficiency and cytotoxic effect in tridimensional model of tumors, Drug Deliv, vol.25, pp.1790-1801, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01996795
Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: The case experience with preclinical mechanistic and early clinical-translational studies, Toxicol. Appl. Pharmacol, vol.224, pp.290-299, 2007. ,
Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin, Photochem. Photobiol, vol.81, pp.849-859, 2005. ,
Temporally and spatially heterogeneous distribution of mTHPC in a murine tumor observed by two-color confocal fluorescence imaging and spectroscopy in a whole-mount model, Photochem. Photobiol, vol.81, pp.1123-1130, 2005. ,
Intracellular localization of photosensitizers, Ciba Found. Symp, vol.146, pp.107-111, 1989. ,
Cholesterol depletion by methyl-?-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma, Mol. Cancer, vol.13, p.204, 2014. ,
Complexation: Cyclodextrins, Encyclopedia of Pharmaceutical Technology, pp.671-696, 2007. ,
Aluminiumphthalocyanine chloride nanoemulsions for anticancer photodynamic therapy: Development and in vitro activity against monolayers and spheroids of human mammary adenocarcinoma MCF-7 cells, J. Nanobiotechnology, vol.13, pp.2225-2238, 2015. ,
Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy, Photochem. Photobiol, vol.85, pp.1053-1074, 2009. ,
The role of apoptosis in response to photodynamic therapy: what, where, why, and how, Photochem. Photobiol. Sci. Off. J. Eur. Photochem. Assoc. Eur. Soc. Photobiol, vol.1, pp.1-21, 2002. ,
,
The potential of photodynamic therapy (PDT)-Experimental investigations and clinical use, Liposomal Drug Delivery Systems and Anticancer Drugs, vol.23, pp.912-929, 2016. ,
, , 2013.
, Potential use of Folate-appended Methyl-?-Cyclodextrin as an, Anticancer Agent. Sci. Rep, vol.3
Dye Sensitizers for Photodynamic Therapy, Materials, vol.6, pp.817-840, 2013. ,
Photodynamic killing of Enterococcus faecalis in dentinal tubules using mTHPC incorporated in liposomes and invasomes, Clin. Oral Investig, vol.19, pp.373-384, 2015. ,
Rose Bengal Acetate PhotoDynamic Therapy (RBAc-PDT) Induces Exposure and Release of Damage-Associated Molecular Patterns (DAMPs) in Human HeLa Cells, PLOS ONE, vol.9, 2014. ,
, , 2006.
, Betamethasone-in-cyclodextrin-in-liposome: The effect of cyclodextrins on encapsulation efficiency and release kinetics, Int. J. Pharm, vol.312, pp.75-82
Photodynamic therapy -hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity, Drug Deliv, vol.26, pp.23-33, 2019. ,
Photophysical Properties of Tin Ethyl Etiopurpurin I (SnET2) and Tin Octaethylbenzochlorin (SnOEBC) in Solution and Bound to Albumin, Photochem. Photobiol, vol.68, pp.809-815, 1998. ,
,
Porphyrins in photodynamic therapy -a search for ideal photosensitizers, Curr. Med. Chem. Anti-Cancer Agents, vol.2, pp.187-207, 2002. ,
Influence of cyclodextrins on the physical stability of DPPC-liposomes, Colloids Surf. B Biointerfaces, vol.58, pp.218-224, 2007. ,
Features of the Interaction between Cyclodextrins and Colloidal Liposomes, J. Incl. Phenom. Macrocycl. Chem, vol.54, pp.89-93, 2006. ,
Native and ?cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer, Drug Deliv, vol.19, pp.346-353, 2012. ,
Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery, J. Pharm. Sci, vol.85, pp.1142-1169, 1996. ,
Photodynamic therapy as a new treatment modality for inflammatory and infectious conditions, Expert Rev. Clin. Immunol, vol.11, pp.637-657, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01215472
Complexation Thermodynamics of Cyclodextrins, Chem. Rev, vol.98, pp.1875-1918, 1998. ,
Interaction of liposomal formulations of meta-tetra(hydroxyphenyl)chlorin (temoporfin) with serum proteins: protein binding and liposome destruction, Photochem. Photobiol, vol.88, pp.1256-1264, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00701915
Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo, Int. J. Nanomedicine, vol.8, pp.3817-3831, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00875936
, , 1998.
, Parameters Affecting Photodynamic Activity of Foscan® or Meta-tetra(hydroxyphenyl)chlorin (mTHPC) In Vitro and In Vivo, Lasers Med. Sci, vol.13, pp.119-125
Photosensitizing effects of m-tetrahydroxyphenylchlorin on human tumor xenografts: correlation with sensitizer uptake, tumor doubling time and tumor histology, Int. J. Cancer, vol.76, pp.872-874, 1998. ,
Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT, J. Photochem. Photobiol. B, vol.96, pp.1-8, 2009. ,
Human tissue levels and plasma pharmacokinetics of temoporfin (Foscan®, mTHPC), Lasers Med. Sci, vol.11, pp.267-272, 1996. ,
Comparative biodistribution of meta-Tetra(Hydroxyphenyl) chlorin in multiple species: clinical implications for photodynamic therapy, Lasers Surg. Med, vol.20, pp.437-442, 1997. ,
Protoporphyrin IX: the Good, the Bad, and the Ugly, J. Pharmacol. Exp. Ther, vol.356, pp.267-275, 2016. ,
Cyclodextrin Inclusion Compounds in Research and Industry, 1980. ,
, Angew. Chem. Int. Ed. Engl, vol.19, pp.344-362
Hybrid nanoparticles for detection and treatment of cancer, Adv. Mater. Deerfield Beach Fla, vol.24, pp.3779-3802, 2012. ,
Liposomal drug delivery systems: an update review, Curr. Drug Deliv, vol.4, pp.297-305, 2007. ,
Investigation of Foscan interactions with plasma proteins, Biochim. Biophys. Acta, vol.1725, pp.394-402, 2005. ,
Redistribution of Foscan® from plasma proteins to model membranes, Photochem. Photobiol. Sci, vol.5, pp.770-777, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00101630
Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin, Arch. Otolaryngol. Head Neck Surg, vol.123, pp.162-168, 1997. ,
Cyclodextrins: a versatile tool in separation science, J. Chromatogr. B. Biomed. Sci. App, vol.745, pp.83-102, 2000. ,
mTHPC -A drug on its way from second to third generation photosensitizer?, Photodiagnosis Photodyn. Ther, vol.9, pp.170-179, 2012. ,
Temoporfin (Foscan®, 5,10,15,20-tetra(mhydroxyphenyl)chlorin)--a second-generation photosensitizer, Photochem. Photobiol, vol.87, pp.1240-1296, 2011. ,
Platelets, photosensitizers, and PDT, Photodiagnosis Photodyn. Ther, vol.10, pp.1-16, 2013. ,
Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease, Cancer Immunol. Immunother. CII, vol.64, pp.287-297, 2015. ,
Cyclodextrins: application in different routes of drug administration, Acta Pharm. Zagreb Croat, vol.55, pp.139-156, 2005. ,
Near-infrared photothermal/photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress, Sci. Rep, vol.7, 2009. ,
, Pharmacokinetics and biodistribution of Photolon® (Fotolon®) in intact and tumor-bearing rats, Photodiagnosis Photodyn. Ther, vol.6, pp.97-104
The Unique Characteristics of Tumor Vasculature and Preclinical Evidence for its Selective Disruption by Tumor-Vascular Disrupting Agents, Cancer Treat. Rev, vol.37, pp.63-74, 2011. ,
, , 1996.
, Liposomes with nifedipine and nifedipine-cyclodextrin complex: calorimetrical and plasma stability comparison, Eur. J. Pharm. Sci, vol.4, pp.359-366
Liposomal drug formulations in cancer therapy: 15 years along the road, Drug Discov. Today, vol.17, pp.160-166, 2012. ,
, , 1994.
, An Efficient Oxygen Independent Two-Photon Photosensitization Mechanism, Photochem. Photobiol, vol.59, pp.135-139
Inclusion complexation, encapsulation interaction and inclusion number in cyclodextrin chemistry, Coord. Chem. Rev, vol.253, pp.1276-1284, 2009. ,
, Cyclodextrins. Toxicol. Pathol, vol.36, pp.30-42, 2008.
Mechanisms of drug release from cyclodextrin complexes, Adv. Drug Deliv. Rev, vol.36, pp.3-16, 1999. ,
,
, Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions, Cancers, vol.9
System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer, J. Biomed. Opt, vol.15, p.58003, 2010. ,
Online dosimetry for temoporfin-mediated interstitial photodynamic therapy using the canine prostate as model, J. Biomed. Opt, vol.21, p.28002, 2016. ,
9-Acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene (ATMPn), a novel photosensitizer for photodynamic therapy: uptake kinetics and intracellular localization, J. Photochem. Photobiol. B, vol.34, pp.67-72, 1996. ,
Introduction and General Overview of Cyclodextrin Chemistry, Chem. Rev, vol.98, pp.1743-1754, 1998. ,
Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development, Adv. Drug Deliv. Rev, vol.36, pp.17-28, 1999. ,
Cyclodextrin-Lipid Complexes: Cavity Size Matters, Struct. Chem, vol.28, pp.479-492, 2017. ,
Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States, J. Urol, vol.196, pp.1096-1104, 2016. ,
Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications, Photodiagnosis Photodyn. Ther, vol.2, pp.175-191, 2005. ,
, , 2003.
, Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultured tumour cells, Br. J. Cancer, vol.88, pp.146-152
Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals, Crit. Rev. Ther. Drug Carrier Syst, vol.14, pp.1-104, 1997. ,
Determining association constants from titration experiments in supramolecular chemistry, Chem Soc Rev, vol.40, pp.1305-1323, 2011. ,
Investigation of aggregates of dyes by the method of resonance light scattering: correction of spectra, Biofizika, vol.54, pp.824-830, 2009. ,
Recent advances with liposomes as pharmaceutical carriers, Nat. Rev. Drug Discov, vol.4, pp.145-160, 2005. ,
Passive and active drug targeting: drug delivery to tumors as an example, Handb. Exp. Pharmacol, pp.3-53, 2010. ,
Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses, BJU Int, vol.102, pp.556-562, 2008. ,
The pharmacokinetic behavior of the photosensitizer meso-tetrahydroxyphenyl-chlorin in mice and men, Cancer Chemother. Pharmacol, vol.60, pp.113-122, 2007. ,
In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy, Photochem. Photobiol, vol.52, pp.375-385, 1990. ,
, , 2011.
, Photosens PDT at the treatment of virus-associated precancer and non-invasive cervical cancer, Photodiagnosis Photodyn. Ther, vol.8, p.217
Cyclodextrins in drug carrier systems, Crit. Rev. Ther. Drug Carrier Syst, vol.3, pp.1-40, 1987. ,
, , 1999.
, Application of supercritical carbon dioxide for the preparation of a piroxicam-betacyclodextrin inclusion compound, Pharm. Res, vol.16, pp.1864-1870
Disposition of 14C-alphacyclodextrin in germ-free and conventional rats, Regul. Toxicol. Pharmacol. RTP, vol.39, issue.1, pp.57-66, 2004. ,
,
Molecular mechanisms and pathophysiology of necrotic cell death, Curr. Mol. Med, vol.8, pp.207-220, 2008. ,
Does tumour uptake of Foscan determine PDT efficacy?, Int. J. Cancer, vol.73, pp.236-239, 1997. ,
Preparation and characterization of liposomes as therapeutic delivery systems: a review, Pharm. Acta Helv, vol.70, pp.95-111, 1995. ,
mTHPC-mediated photodynamic therapy of early stage oral squamous cell carcinoma: a comparison to surgical treatment, Ann. Surg. Oncol, vol.20, pp.3076-3082, 2013. ,
Cyclodextrin based novel drug delivery systems, J. Incl. Phenom. Macrocycl. Chem, vol.62, pp.23-42, 2008. ,
Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study, Hepatol. Baltim. Md, vol.62, pp.1456-1465, 2015. ,
Clinical evaluation of the cutaneous phototoxicity of 5, Photochem. Photobiol, vol.10, pp.382-387, 1998. ,
Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-?-cyclodextrin-in-liposome, J. Pharm. Sci, vol.100, pp.3357-3364, 2011. ,
The effects of photodynamic therapy with Photodithazine on HPV 16 E6/E7 associated cervical cancer model, J. Porphyr. Phthalocyanines, vol.15, pp.174-180, 2011. ,
A Comparison of the Sensitivity to Photodynamic Treatment of Endothelial and Tumour Cells in Different Proliferative States, Int. J. Radiat. Biol, vol.58, pp.145-156, 1990. ,
Comparison of the influence of a water-soluble polymer carrier on the tumor localization and biodistribution of mesotetrametahydroxyphenylchlorin (mTHPC) in two animal models, 5th International Photodynamic Association Biennial Meeting, (International Society for Optics and Photonics), pp.45-51, 1995. ,
Distribution of temoporfin, a new photosensitizer for the photodynamic therapy of cancer, in a murine tumor model, Photochem. Photobiol, vol.61, pp.397-401, 1996. ,
Soret band shape indicates mTHPC distribution between ?-cyclodextrins and serum proteins, Dyes Pigments, vol.137, pp.299-306, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01418967
The alteration of temoporfin distribution in multicellular tumor spheroids by ?-cyclodextrins, Int. J. Pharm, vol.529, pp.568-575, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01726347
Temoporfin-in-Cyclodextrin-in-Liposome-A New Approach for Anticancer Drug Delivery: The Optimization of Composition, vol.8, p.847, 2018. ,
Evaluation of temoporfin affinity to ?-cyclodextrins assuming selfaggregation, J. Photochem. Photobiol. Chem, vol.367, pp.13-21, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01861135
Current state of the nanoscale delivery systems for temoporfin-based photodynamic therapy: Advanced delivery strategies, J. Controlled Release, vol.304, pp.268-287, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02179885
Optical Methods for the Analysis of the Temoporfin Photosensitizer References Distribution Between Serum Proteins and Methyl-?-Cyclodextrin Nanocarriers in Blood Serum, J. Appl. Spectrosc, vol.84, pp.1030-1036, 2018. ,
Inclusion complexation with ?-cyclodextrin derivatives alters photodynamic activity and biodistribution of meta-tetra(hydroxyphenyl)chlorin, Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci, vol.91, pp.172-182, 2016. ,
Lutetium Texaphyrin (PCI-0123): A Near-Infrared, Water-Soluble Photosensitizer, Photochem. Photobiol, vol.63, pp.892-897, 1996. ,
Cellular uptake, subcellular localization and photodamaging effect of temoporfin (mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative, Cancer Lett, vol.157, pp.123-131, 2000. ,
Effect of the Incorporation of Functionalized Cyclodextrins in the Liposomal Bilayer, Molecules, vol.24, p.1387, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02330479
An updated overview on the development of new photosensitizers for anticancer photodynamic therapy, Acta Pharm. Sin. B, vol.8, pp.137-146, 2018. ,
,
, Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration, J. Pharm. Pharmacol, vol.65, pp.1107-1117
Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies, Biochim. Biophys. Acta, vol.1768, pp.1311-1324, 2007. ,
, SCIENTIFIC OUTPUT ARTICLES IN PEER-REVIEWED JOURNALS
Current state of the nanoscale delivery systems for temoporfin-based photodynamic therapy: Advanced delivery strategies, J Control Release, vol.304, pp.268-287, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02179885
Stroma-Rich Co-Culture Multicellular Tumor Spheroids as a Tool for Photoactive Drugs Screening, J Clin Med, vol.8, issue.10, p.1686, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02418797
The targeting ability of fluorescent quantum dots to the folate receptor rich tumors, Photodiagn. Photodyn, vol.26, pp.150-156, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02266463
Investigation of the properties of a three-dimensional cell tumor model, Bulletin of RSMU, vol.6, pp.14-20, 2018. ,
mTHPC-loaded extracellular vesicles outperform liposomal and free mTHPC formulations by an increased stability, drug delivery efficiency and cytotoxic effect in tridimensional model of tumors, Drug Deliv, vol.25, issue.1, pp.1790-1801, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01996795
Temoporfinin-cyclodextrin-in-liposome -a new approach for anticancer drug delivery: the optimization of composition, Nanomaterials, vol.8, issue.10, pp.847-861, 2018. ,
Fluorescent nanoparticles for the guided surgery of ovarian peritoneal carcinomatosis, Nanomaterials, vol.8, pp.572-592, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01860308
Evaluation of temoporfin affinity to ?-cyclodextrins assuming self-aggregation, J Photochem Photobiol A, vol.367, pp.13-21, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01861135
Optical Methods for the Analysis of the Temoprofin Photosensitizer Distribution Between Serum Proteins and Methyl?-Cyclodextrin Nanocarriers in Blood Serum, J Appl Spectrosc, vol.84, pp.1030-1036, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01861165
The alteration of temoporfin distribution in multicellular tumor spheroids by ?cyclodextrins, Int Journal Pharm, vol.529, pp.568-575, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01726347
Drug delivery to solid tumors: The predictive value of the multicellular tumor spheroid model for nanomedicine screening, Int J Nanomed, vol.12, pp.7993-8007, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01660398
Investigation of chlorin photosensitizers distribution in monolayer and spheroid cell cultures, Biomedical Photonics, vol.6, issue.2, pp.4-11, 2017. ,
Soret band shape indicates mTHPC distribution between ?-cyclodextrins and serum proteins, Dyes Pigm, vol.137, pp.299-306, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01418967
Inclusion complexation with ?-cyclodextrin derivatives alters biodistribution and photosensitizing efficacy of meta-tetra(hydroxyphenyl)chlorin, Eur J Pharm Sci, vol.91, pp.172-182, 2016. ,
,
Cyclodextrin-based photoactive liposomal nanoparticles for tumor targeting. 17 th International Photodynamic association World Congress, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-01862333
Cyclodextrin-based photoactive liposomal nanoparticles for tumor targeting, ESP-IUPB World Congress, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-01862333
Temoporphin-in-Cyclodextrin-in-Liposome nanoparticles for tumor targeting, Pharmaceutics & Novel Drug Delivery Systems, vol.10, p.32, 2018. ,
mTHPC-in-cyclodextin-in-liposome nanodelivery system. 11 th European and Global Summit for Clinical Nanomedicine, Targeted Delivery and Precision Medicine (CLINAM), vol.230, 2018. ,
Optimization of the composition of liposomal-based hybrid nanoparticles for mTHPC delivery. 4 th International conference Current Trends in Cancer Theranostics, vol.74, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01864534
Cyclodextrin-based photoactive liposomal nanoparticles for tumor targeting. 2 nd Edition of Global Conference on Pharmaceutics and Drug Delivery Systems, vol.26, pp.4-6, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01862333
, Cyclodextrins as nanodelivery system in mTHPC-PDT. 16 th International Photodynamic Association World Congress, vol.65, 2017.
Investigation of Ce6 accumulation and distribution in cell cultures of head and neck cancers, Optical and Nano-Technologies for Biology and Medicine, pp.23-27, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02404290
Natural nanocarriers-based mTHPC for the photodynamic therapy, International Conference On Nanomedicine And Nanobiotechnology, vol.176, 2018. ,
Nanoparticle-based mTHPC delivery in the photodynamic therapy of cancer, International Conference Laser Optics (ICLO), vol.583, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01861050
Comparitive accumulation study of chlorin group photosensitizers on monolayer and multicellular tumor spheroids of cell culture, International Conference Laser Optics (ICLO), p.589, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01863262
Alteration of temoporfin pharmacokinetics by ?-cyclodextrin derivatives, Applied Nanotechnology and Nanoscience International Conference -ANNIC 2017, pp.118-120, 2017. ,
Influence of mTHPC liposomal distribution in multicellular spheroid on the photodynamic therapy efficacy, vol.114, 2016. ,